Target intelligence / Profile preview

MPP7 divergent transcript (MPP7-DT)

Target
MPP7-DT
Molecular classification
Other, long non-coding RNA, divergent transcript
01

Overview

MPP7 divergent transcript (MPP7-DT) refers to a putative long non-coding RNA (lncRNA) transcribed in a divergent orientation from the promoter region of the MPP7 gene. Divergent transcription is a common phenomenon in mammalian genomes, producing non-coding RNAs that arise upstream and antisense to coding genes[2][6]. While divergent transcripts can sometimes play a role in transcriptional regulation, particularly for developmental regulators, there is no current evidence that MPP7-DT itself is a defined molecular entity, functional gene product, or therapeutic target. MPP7-DT appears as a database placeholder for such an antisense or upstream transcript, and not as a characterized receptor, enzyme, or disease target[3]. Key reasons why this is not a standard target and is marked as incorrect: - There is no evidence that "MPP7 divergent transcript" has been characterized as a gene product with function, nor is it a protein, receptor, or established target class. - Divergent transcripts are widespread, and many have unknown function; their naming follows systematic annotation rather than functional characterization[2][6]. - No aliases, drugs, or disease/biomarker information is associated with MPP7-DT. In summary, "MPP7 divergent transcript" is a bioinformatic annotation for a possible divergent long non-coding RNA from the MPP7 gene locus, not a validated molecule or therapeutic target[2][3][6].

Other names
MPP7 divergent transcriptMPP7-DT
02

Biological functions

Possible transcriptional regulation (by analogy to other divergent lncRNAs)
03

Disease associations

None known for the transcript itself; MPP7 protein has cancer relevance, but "MPP7 divergent transcript" lacks evidence.

Beyond the preview

Go deeper on MPP7 divergent transcript (MPP7-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPP7 divergent transcript (MPP7-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call